STOCK TITAN
  1. Home
  2. Sec-filings
  3. SER
  4. [EFFECT] Serina Therapeutics, Inc. SEC Filing

[EFFECT] Serina Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 13, 2026 4:00 P.M.
Form: S-3
CIK: 0001708599
Company Name: Serina Therapeutics, Inc.
File Number: 333-293107

Source: View Original Filing on SEC EDGAR

Stock SER logo
Serina Therapeutics

NYSE:SER

SER Rankings

#6114 Ranked by Market Cap
N/A Ranked by Dividends
#109 Top Loser

SER Latest News

Feb 19, 2026
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Feb 3, 2026
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event
Jan 28, 2026
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
Jan 15, 2026
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
Dec 11, 2025
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

SER Latest SEC Filings

Feb 17, 2026
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity
Feb 17, 2026
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity
Feb 17, 2026
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity
Feb 17, 2026
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity
Feb 3, 2026
[Form 4] Serina Therapeutics, Inc. Insider Trading Activity

SER Stock Data

18.12M
5.62M
Biotechnology
Pharmaceutical Preparations
Link
United States
HUNTSVILLE